OncoSec Medical (FRA:ONMA) Interest Expense : €-0.05 Mil (TTM As of Jan. 2023)

View and export this data going back to 2015. Start your Free Trial

What is OncoSec Medical Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. OncoSec Medical's interest expense for the three months ended in Jan. 2023 was € -0.03 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jan. 2023 was €-0.05 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. OncoSec Medical's Operating Income for the three months ended in Jan. 2023 was € -7.11 Mil. OncoSec Medical's Interest Expense for the three months ended in Jan. 2023 was € -0.03 Mil. OncoSec Medical did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

OncoSec Medical Interest Expense Historical Data

The historical data trend for OncoSec Medical's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoSec Medical Interest Expense Chart

OncoSec Medical Annual Data

Trend

Jul13

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Interest Expense

Get a 7-Day Free Trial

-0.01

-0.02

OncoSec Medical Quarterly Data
	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23
Interest Expense	Get a 7-Day Free Trial															-	-	-0.01	-0.01	-0.03

OncoSec Medical Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jan. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.05 Mil.

OncoSec Medical (FRA:ONMA) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

OncoSec Medical's Interest Expense for the three months ended in Jan. 2023 was €-0.03 Mil. Its Operating Income for the three months ended in Jan. 2023 was €-7.11 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jan. 2023 was €1.97 Mil.

OncoSec Medical's Interest Coverage for the quarter that ended in Jan. 2023 is calculated as

OncoSec Medical did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

OncoSec Medical (FRA:ONMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoSec Medical Inc (FRA:ONMA) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

ONCSQ:USA

Address

24 North Main Street, Pennington, NJ, USA, 08534

Website

https://www.oncosec.com

OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.

OncoSec Medical (FRA:ONMA) Headlines

No Headlines